Methods of administering inhibitory anti-factor XII/XIIA monoclonal antibodies

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9856326
SERIAL NO

15343447

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to inhibitory anti-factor XII/FXIIa antibodies and methods of their use.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CSL BEHRING GMBH35041 MARBURG

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Nash, Andrew Kew, AU 31 232
Nolte, Marc Michelbach, DE 54 197
Panousis, Con Melbourne, AU 41 151
Rayzman, Veronika McKinnon, AU 10 81
Schmidbauer, Stefan Lahntal, DE 8 98
Wilson, Michael Elwood, AU 124 2803

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jul 2, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 2, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00